Fusion Antibodies PLC (FAB) — Financial Flexibility Index
Fusion Antibodies PLC (FAB) has a Financial Flexibility Index of -0.47x as of September 2025. Free cash flow of GBX-515.00K (operating CF GBX-575.00K minus capex GBX60.00K) represents 0% of total liabilities (GBX1.09 Million). Check FAB total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Fusion Antibodies PLC Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Fusion Antibodies PLC across 11 annual periods. For the full cash flow conversion analysis, see Fusion Antibodies PLC (FAB) cash flow conversion.
Annual Financial Flexibility Index for Fusion Antibodies PLC (2015–2025)
Year-by-year free cash flow to debt coverage for Fusion Antibodies PLC. Explore Fusion Antibodies PLC debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.07x | GBX-1.35 Million | GBX-1.36 Million | GBX654.00K | ▲ +26.5% |
| 2024 | -2.82x | GBX-1.77 Million | GBX-1.77 Million | GBX627.00K | ▼ -61.3% |
| 2023 | -1.75x | GBX-1.64 Million | GBX-1.75 Million | GBX939.00K | ▼ -2887.9% |
| 2022 | -0.06x | GBX-72.00K | GBX-330.00K | GBX1.23 Million | ▲ +91.9% |
| 2021 | -0.73x | GBX-786.00K | GBX-1.15 Million | GBX1.08 Million | ▼ -1463.6% |
| 2020 | -0.05x | GBX-57.00K | GBX-166.00K | GBX1.23 Million | ▼ -114.6% |
| 2019 | 0.32x | GBX282.23K | GBX-1.10 Million | GBX888.53K | ▼ -61.4% |
| 2018 | 0.82x | GBX521.79K | GBX77.19K | GBX633.59K | ▲ +600.9% |
| 2017 | 0.12x | GBX52.90K | GBX-37.37K | GBX450.22K | ▼ -87.4% |
| 2016 | 0.93x | GBX382.33K | GBX346.57K | GBX411.43K | ▲ +209.7% |
| 2015 | -0.85x | GBX-170.85K | GBX-182.05K | GBX201.67K | — |